| Typicality: | 0.561 |
| Saliency: | 0.539 |
| with the best standard therapy | 5 | other |
| to ensure scientific rigor | 4 | purpose |
| as a control | 4 | manner |
| trial → be → placebo-controlled | 31 |
| trial → use → placebo | 26 |
| trial → receive → placebo | 9 |
| trial → include → placebo | 9 |
| trial → use → placebo controls | 4 |
| trial → be on → placebo | 4 |
| trial → be → placebo | 3 |
| negative | neutral | positive |
| 0.164 | 0.733 | 0.103 |
| Raw frequency | 86 |
| Normalized frequency | 0.539 |
| Modifier score | 0.750 |
| Perplexity | 74.659 |